Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
144 USD | +3.58% | +8.69% | -20.54% |
Apr. 23 | Sector Update: Health Care Stocks Rise in Afternoon Trading | MT |
Apr. 23 | BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer; Shares Rise | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.54% | 14.52B | |
-0.57% | 105B | |
+4.10% | 97.5B | |
+1.60% | 22.19B | |
-15.34% | 21.33B | |
-7.84% | 18.68B | |
-41.41% | 16.6B | |
+7.00% | 14.09B | |
+22.62% | 10.99B | |
-21.51% | 8.63B |
- Stock Market
- Equities
- BGNE Stock
- News BeiGene, Ltd.
- European Commission Approves BeiGene's Chronic Lymphocytic Leukemia Treatment; Shares Slip 3%